Market Overview:
A solid tumor can characterized by growth of abnormal mass or lump of
tissues without liquid or cysts. It is classified into malignant tumor
(cancerous) and the benign tumor (non-cancerous). Additionally, based on the
cell type, tumors can be classified as sarcomas, carcinomas, and lymphomas.
Competitive Landscape:
Abbott Laboratories
Inc., Biogen Idec Incorporated, AstraZeneca Plc., Johnson & Johnson
Company, Amgen Inc., Bristol Myers Squibb Company, GlaxoSmithKline Plc.,
Sanofi, and Baxter International Incorporated
Key Market Drivers:
Growing popularity of biosimilars therapies is driving growth of the solid
tumors treatment market. Moreover, rising prevalence of solid tumors is
fueling market growth. According to the Centers for Disease Control and Prevention, in the
United States in 2019, 1,752,735 new cancer cases were reported and 599,589
people died of cancer. For every 100,000 people, 439 new cancer cases were
reported and 146 people died of cancer.
Growing merger &acquisition in the market of cancer therapies by key
players is again contributing to market growth. For instance, in July 2022, Takeda announced that it has acquire Adaptate
Biotherapeutics to develop novel Gamma Delta (γδ) T Cell Engager therapies
targeting solid tumors.
Covid-19 Impact
Analysis
The COVID-19
pandemic crisis has had significant impact on the practice of tumor treatment.
There was disruption in supply of raw materials used for production of solid tumor drug due to lockdown and
social distancing norms.
Key Takeaways:
1.
The solid tumors
treatment market is expected to exhibit a CAGR of XX % over the forecast owing
to the growing prevalence of solid tumors and increasing popularity of
biosimilar. According to the IQVIA, the three most recently launched
biosimilars in 2019 have achieved significant uptake within their first year:
bevacizumab (42%), trastuzumab (38%), and rituximab (20%).
2.
North America is
expected to gain significant growth over the forecast period owing to the
presence of well-established healthcare sector.
Comments
Post a Comment